Future science at the molecular level
Brad Pentelute and his lab compel the anthrax delivery system to deliver antibody and peptide variants into cells to treat cancer.
Brad Pentelute and his lab compel the anthrax delivery system to deliver antibody and peptide variants into cells to treat cancer.
The findings could help doctors identify cancer patients who would benefit the most from drugs called checkpoint blockade inhibitors.
The Koch Institute’s Annual Symposium highlights emerging successes and challenges in the advancement of vaccines to prevent and treat cancer.
Predictions from the OncoNPC model could enable doctors to choose targeted treatments for difficult-to-treat tumors.
In addition to turning on genes involved in cell defense, the STING protein also acts as an ion channel, allowing it to control a wide variety of immune responses.
The new device, which can be incorporated into a bra, could allow more frequent monitoring of patients at high risk for breast cancer.
MIT researchers find timing and dosage of DNA-damaging drugs are key to whether a cancer cell dies or enters senescence.
Ultrasound research specialist and 2023 MIT Excellence Award winner Nicole Henning adapts ultrasound technology for more sensitive, less invasive imaging for disease modeling.
The device detects the same molecules that cell receptors do, and may enable routine early screening for cancers and other diseases.
The new strategy may enable engineered T cells to eradicate solid tumors such as glioblastoma.
While developing targeted drug-delivery methods, the PhD student advocates for inclusion, belonging, and collaboration.
Omer Yilmaz’s work on how diet influences intestinal stem cells could lead to new ways to treat or prevent gastrointestinal cancers.
The chemical engineer is honored for her work designing polymers and nanomaterials with wide-ranging applications in medicine and energy.
A cancer vaccine combining checkpoint blockade therapy and a STING-activating drug eliminates tumors and prevents recurrence in mice.
With the new method, scientists can explore many cancer mutations whose roles are unknown, helping them develop new drugs that target those mutations.